Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003CA2483602A1 Fgf variants and methods for use thereof
11/20/2003CA2483142A1 Use of vegf for treating bone defects
11/20/2003CA2482690A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein
11/20/2003CA2474947A1 Combination of a growth factor and a protease enzyme
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362915A1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
11/19/2003EP1362914A2 Histone deacetylase inhibitor and use thereof
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362865A1 Cyclic peptide
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362845A2 New process for the synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and their use in the synthesis of perindopril
11/19/2003EP1362600A1 Pharmaceutical compositions containing decoy and method of using the same
11/19/2003EP1362597A1 Antigenic peptides derived from telomerase
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362595A1 Stable fibrinogen solution
11/19/2003EP1362127A2 Serpin drugs for treatment of hiv infection and method of use thereof
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/19/2003EP1362100A2 Novel p53-inducible protein
11/19/2003EP1362098A2 Thioredoxin derived from h. pylori, which is cabable of inhibiting nf-kappa b activation
11/19/2003EP1362097A2 Champ-a cardiac helicase-like factor
11/19/2003EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1361898A2 Modulated release particles for aerosol delivery
11/19/2003EP1361897A2 Methods for inhibiting pain
11/19/2003EP1361896A2 Localized myocardial injection method for treating ischemic myocardium
11/19/2003EP1361894A2 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke acting as a health protecting agent during smoking
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361888A2 Method of treating neurologcial diseases
11/19/2003EP1361887A2 Angiogenically effective unit dose of fgf-2 and method of use
11/19/2003EP1361886A2 Methods and compositions for inhibiting hiv-coreceptor interactions
11/19/2003EP1361885A1 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361878A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
11/19/2003EP1361867A1 Fibrate-statin combinations with reduced fed-fasted effects
11/19/2003EP1361861A1 Modulated release particles for aerosol delivery
11/19/2003EP1361860A1 Modulated release particles for aerosol delivery
11/19/2003EP1361859A1 Modulated release particles for aerosol delivery
11/19/2003EP1361858A2 Modulated release particles for aerosol delivery
11/19/2003EP1361850A1 Use of (gamma-hydroxy-n-methyl-l-leucine9) cyclosporin a for hair growth
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
11/19/2003EP1240350A4 P2y12 receptor
11/19/2003EP1185248A4 Supercritical fluid-assisted nebulization and bubble drying
11/19/2003EP1173198B1 Use of a determined hyaluronidase to eliminate corneal scars, opacification and haze
11/19/2003EP1140150B1 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP1060190B1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0914830B1 Neovascularization inhibitor containing tissue factor pathway inhibitor
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0756449B1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003EP0719779B1 Substituted thiazolo [3,2-alpha]azepine derivative
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/19/2003CN1457258A Methods of treating viral diseases with IL-18 and IL-18 compositions
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1457255A Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
11/19/2003CN1456669A Method for producing human insulin by transgene romaine lettuce, tomato and tobaco
11/19/2003CN1456573A Nacre substrate protein, coding gene and cloning method and application thereof
11/19/2003CN1456353A Senile dementia vaccinum and preparing method thereof
11/19/2003CN1456352A Medicinal composition containing fiber eliminating enzyme
11/19/2003CN1456351A Self-emulsifying agglomerant of oral polypeptide medicine
11/19/2003CN1456350A Eye cyclosporin gel
11/19/2003CN1456349A Biological preparation containing marine active substance and use thereof
11/19/2003CN1128220C Process for separating worm kinase
11/19/2003CN1128155C Colored mistletoe herb goycoprotein extraction and its medicine composite and preparation
11/18/2003US6649747 Composition and method for diagnosing auto-immune hepatitis
11/18/2003US6649746 Isolated nucleotide sequence encoding a peptide comprising a protease cleavage site; rehydration due to diarrhea and nutrition therapy
11/18/2003US6649743 Monoclonal antibody against estrogen stimulated leucine aminopeptidase
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649739 Protein, its gene, reagents for inducing apoptosis, and anticancer agent
11/18/2003US6649738 Pancreas-derived plasminogen activator inhibitor
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649617 Treatment for stroke management
11/18/2003US6649597 Delivery vehicle construct which specifically binds to and stimulates endocytosis into cells expressing the activator
11/18/2003US6649596 Modified VEGF Oligonucleotides for Inhibition of tumor growth
11/18/2003US6649594 Compositions for metabolic protection and repair of lips
11/18/2003US6649593 Amino acid derivatives including serine, leucine, valine, arginine, asparginine, methionine, glycine and phenylalanine units; S1 protease inhibition; modulation of cholesterol homeostasis in cells
11/18/2003US6649592 Peptide inhibitors of LFA-1/ICAM-1 interaction
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649588 Using ebaf protein from amino acid sequence 2
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/18/2003US6649407 Viral fiber protein for use in the treatment of viral diseases
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649387 Enzymatic oxidative deamination process
1 ... 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 ... 3163